Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES)

被引:56
|
作者
Titus-Ernstoff, Linda
Troisi, Rebecca
Hatch, Elizabeth E.
Wisei, Lauren A.
Palmer, Julie
Hyer, Marianne
Kaufman, Raymond
Adam, Ervin
Strohsnitter, William
Noller, Kenneth
Herbst, Arthur L.
Gibson-Chambers, Jennifer
Hartge, Patricia
Hoover, Robert N.
机构
[1] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
[3] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[4] Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA
[5] Boston Univ, Sch Publ Hlth, Slone Epidemiol Ctr, Boston, MA 02215 USA
[6] Informat Management Serv Inc, Rockville, MD 20852 USA
[7] Methodist Hosp, Dept Obstet & Gynecol, Houston, TX 77030 USA
[8] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA
[9] Tufts Univ New England Med Ctr, Dept Obstet & Gynecol, Boston, MA 02111 USA
[10] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA
关键词
diethylstilbestrol; prenatal exposure; maternal exposure; menstruation; reproductive histories; infertility; epigenetic alternations;
D O I
10.1093/ije/dyl106
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background In women, prenatal exposure to diethylstilbestrol (DES) is associated with adult reproductive dysfunction. The mouse model, which replicates many DES outcomes, suggests DES causes epigenetic alterations, which are transmissable to daughters of prenatally exposed animals. We report menstrual and reproductive characteristics in a unique cohort comprising daughters of women exposed prenatally to DES. Methods Menstrual and reproductive outcomes and baseline characteristics were assessed by mailed questionnaire in 793 women whose mothers had documented information regarding in utero DES exposure. Results Mean age at menarche was 12.6 years in both groups, but daughters of the exposed women attained menstrual regularization later (mean age of 16.2 years vs. 15.8 years; P = 0.05), and were more likely to report irregular menstrual periods, odds ratio (OR) = 1.54 [95% confidence interval (95% CI 1.02-2.32)]. A possible association between mothers' DES exposure and daughters' infertility was compatible with chance, age, and cohort adjusted OR = 2.19 (95% CI 0.95-5.07). We found limited evidence that daughters of the exposed had more adverse reproductive outcomes, but daughters of exposed women had fewer live births (1.6) than the unexposed (1.9) (P = 0.005). Conclusions The high risk of reproductive dysfunction seen in women exposed to DES in utero was not observed in their daughters, but most women in our cohort have not yet attempted to start their families, and further follow-up is needed to assess their reproductive health. Our findings of menstrual irregularity and possible infertility in third-generation women are preliminary but compatible with speculation regarding transgenerational transmission of DES-related epigenetic alterations in humans.
引用
收藏
页码:862 / 868
页数:7
相关论文
共 50 条
  • [1] Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study
    Titus, Linda
    Hatch, Elizabeth E.
    Drake, Keith M.
    Parker, Samantha E.
    Hyer, Marianne
    Palmer, Julie R.
    Strohsnitter, William C.
    Adam, Ervin
    Herbst, Arthur L.
    Huo, Dezheng
    Hoover, Robert N.
    Troisi, Rebecca
    REPRODUCTIVE TOXICOLOGY, 2019, 84 : 32 - 38
  • [2] Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES)
    Titus-Ernstoff, L.
    Troisi, R.
    Hatch, E. E.
    Palmer, J. R.
    Hyer, M.
    Kaufman, R.
    Adam, E.
    Noller, K.
    Hoover, R. N.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 (02): : 377 - 383
  • [3] Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES) Panel discussion
    Juul, Anders
    Titus-Ernstoff, Linda
    Skakkebaek, Niels E.
    Jensen, Tina K.
    Soto, Ana
    Swan, Shanna
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 (02): : 383 - 384
  • [4] Screening for cancers of the cervix and vagina for women exposed to diethylstilbestrol (DES) in utero
    Tournaire, Michel
    Devouche, Emmanuel
    Lafaye, Nathalie
    Levadou, Anne
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (07)
  • [5] Adverse health effects in children of women exposed in utero to diethylstilbestrol (DES)
    Tournaire, Michel
    Epelboin, Sylvie
    Devouche, Emmanuel
    Viot, Geraldine
    Le Bidois, Jerome
    Cabau, Anne
    Dunbavand, Annabel
    Levadou, Anne
    THERAPIE, 2016, 71 (04): : 395 - 404
  • [6] Genital tract and reproductive characteristics in daughters of women and men prenatally exposed to diethylstilbestrol (DES)
    Wautier, Anne
    Tournaire, Michel
    Devouche, Emmanuel
    Epelboin, Sylvie
    Pouly, Jean-Luc
    Levadou, Anne
    THERAPIE, 2020, 75 (05): : 439 - 448
  • [7] Hypospadias in sons of women exposed to diethylstilbestrol in utero
    Palmer, JR
    Wise, LA
    Robboy, SJ
    Titus-Ernstoff, L
    Noller, KL
    Herbst, AL
    Troisi, R
    Hoover, RN
    EPIDEMIOLOGY, 2005, 16 (04) : 583 - 586
  • [8] Hypospadias in sons of women exposed to diethylstilbestrol in utero
    Pons, JC
    Papiernik, E
    Billon, A
    Hessabi, M
    Duyme, M
    PRENATAL DIAGNOSIS, 2005, 25 (05) : 418 - 419
  • [9] Cancer Risk in Women Exposed to Diethylstilbestrol in Utero
    Tournaire, Michel
    Devouche, Emmanuel
    Espie, Marc
    Asselain, Bernard
    Levadou, Anne
    Cabau, Anne
    Dunbavand, Annabel
    Grosclaude, Pascale
    Epelboin, Sylvie
    THERAPIE, 2015, 70 (05): : 433 - 441